The R2 subunit of ribonucleotide reductase from herpes simplex virus type 2 was overproduced with prokaryotic and eukaryotic expression systems. The recombinant R2 purified by a two-step procedure exhibited a 3-fold higher activity when produced in eukaryotic cells. Precise quantification of the R2 concentration at each step of the purification indicated that the activity was not altered during the purification procedure. Moreover, we have observed that the level of R2 expression, in eukaryotic cells as well as in prokaryotic cells, did not influence R2 activity. Extensive characterization of the recombinant R2 purified from eukaryotic and prokaryotic expression systems has shown that both types of pure R2 preparations were similar in their 76 kDa dimer contents (more than 95%) and in their ability to bind the R1 subunit. However, we have found that the higher activity of R2 produced in eukaryotic cells is more probably related to a higher capability of binding the iron cofactor as well as a 3-fold greater ability to generate the tyrosyl free radical.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
November 1996
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Research Article|
November 15 1996
Production of the R2 subunit of ribonucleotide reductase from herpes simplex virus with prokaryotic and eukaryotic expression systems: higher activity of R2 produced by eukaryotic cells related to higher iron-binding capacity Available to Purchase
Nathalie LAMARCHE;
Nathalie LAMARCHE
*Institut du cancer de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke Est, Montréal, Canada H2L 4M1
†Institut de Recherches en Biotechnologie (CNRC), 6100 avenue Royalmount, Montréal, Canada H4P 2R2
Search for other works by this author on:
Gilles MATTON;
Gilles MATTON
*Institut du cancer de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke Est, Montréal, Canada H2L 4M1
Search for other works by this author on:
Bernard MASSIE;
Bernard MASSIE
†Institut de Recherches en Biotechnologie (CNRC), 6100 avenue Royalmount, Montréal, Canada H4P 2R2
Search for other works by this author on:
Marc FONTECAVE;
Marc FONTECAVE
‡Université Joseph Fourier Chimie Recherche, 301 rue de la Chimie, Saint-Martin d'Hères, B.P. 53X F-30041 Grenoble Cedex, France
Search for other works by this author on:
Mohamed ATTA;
Mohamed ATTA
‡Université Joseph Fourier Chimie Recherche, 301 rue de la Chimie, Saint-Martin d'Hères, B.P. 53X F-30041 Grenoble Cedex, France
Search for other works by this author on:
France DUMAS;
France DUMAS
†Institut de Recherches en Biotechnologie (CNRC), 6100 avenue Royalmount, Montréal, Canada H4P 2R2
Search for other works by this author on:
Pierrette GAUDREAU;
Pierrette GAUDREAU
§Laboratoire de Neuroendocrinologie, Centre de Recherche Louis-Charles Simard de l'Hôpital Notre-Dame, 1560 Sherbrooke Est, Montréal, Canada H2L 4M1
Search for other works by this author on:
Yves LANGELIER
Yves LANGELIER
‖
*Institut du cancer de Montréal, Hôpital Notre-Dame, 1560 Sherbrooke Est, Montréal, Canada H2L 4M1
‖To whom correspondence should be addressed.
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
April 04 1996
Revision Received:
June 28 1996
Accepted:
July 19 1996
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London © 1996
1996
Biochem J (1996) 320 (1): 129–135.
Article history
Received:
April 04 1996
Revision Received:
June 28 1996
Accepted:
July 19 1996
Citation
Nathalie LAMARCHE, Gilles MATTON, Bernard MASSIE, Marc FONTECAVE, Mohamed ATTA, France DUMAS, Pierrette GAUDREAU, Yves LANGELIER; Production of the R2 subunit of ribonucleotide reductase from herpes simplex virus with prokaryotic and eukaryotic expression systems: higher activity of R2 produced by eukaryotic cells related to higher iron-binding capacity. Biochem J 15 November 1996; 320 (1): 129–135. doi: https://doi.org/10.1042/bj3200129
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |